Global Pathogen Reduction Systems Market Report and Forecast 2024-2032

Pathogen Reduction Systems Market Size

The global pathogen reduction systems market is expected to grow at a CAGR of 19.8% during the forecast period of 2024-2032, driven by the rising incidence of bloodborne diseases, advancements in pathogen reduction systems, and increasing focus on patient safety across the globe.

Pathogen Reduction Systems Market Outlook

• The increasing number of blood donations and transfusions is driving the demand for pathogen reduction systems.

• The stringent guidelines and recommendations for blood safety by regulatory agencies impact the market dynamics significantly.

• The growing demand for plasma-derived therapies and rising technological advancements in pathogen reduction systems are major market trends.

Pathogen Reduction Systems Market Overview

Pathogens are microorganisms that can potentially cause infections and diseases in the human body. Pathogen reduction system refers to the processes and technologies that are used to decontaminate blood and blood products, thereby preventing the spread of infections from the unfiltered blood to the other individual upon transfusion. There are various methods of pathogen reduction which include ultraviolet (UV) light, filtration treatments, and photochemical treatments. UV light and photochemical treatments damage the nucleic acid of the bacteria making them inactive. Blood and blood products can also be passed through the bacterial filters with a pore size that would not allow the pathogens to pass through it.

 
The COVID-19 pandemic has increased awareness about pathogen-transmitted infections and the importance of blood safety and infection-curbing measures. This has fuelled the demand for the pathogen reduction systems market in the past few years. The market growth is also driven by the increasing prevalence of infectious diseases, rising awareness about the infections caused during transfusions, and blood safety regulations. Technological advances in this field have led to the development of systems that destroy pathogens in blood products without compromising the properties of blood and its components. Thus, the rising investment in innovative and technologically advanced products is poised to impact market dynamics.

Pathogen Reduction Systems Market Growth Drivers

Growing Number of Blood Donations and Transfusions Driving the Market Growth

According to the World Health Organization (WHO ), around 118.5 million blood donations are collected worldwide, out of which around 40% are collected in high-income countries. The most frequently transfused group in high-income countries is reported to be patients aged over 60 years, comprising 60% of all blood transfusions. However, in low-income countries, children under 5 years of age account for 54% of blood transfusions. Further, the blood donation rate is estimated to be 31.5 donations based on samples of 1000 people. Thus, the increasing number of blood donations and transfusions is a primary driver of the market for pathogen reduction systems.

Pathogen Reduction Systems Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Rising Technological Advancements in Pathogen Reduction Systems to Affect the Market Landscape

One of the significant market trends is the rising technological advancements in pathogen reduction systems. Several market players are heavily investing in the development of cost-effective systems with better pathogen inactivation capabilities. The rising innovations in photochemical treatment, UV light technology, and advanced filtration methods are making pathogen reduction systems more effective and are expected to boost market growth in the forecast period.

Growing Adoption of Plasma-Derived Therapies to Augment Pathogen Reduction Systems Market Demand

The increasing demand for plasma-derived therapies for treating conditions such as immune deficiencies and bleeding disorders is a major trend that is poised to aid market growth. This market trend is leading to an increased focus on using pathogen reduction systems to ensure the safety of plasma and plasma-derived products. In addition, the increase in the volume of plasma donations and the production of plasma-based therapies is likely to further bolster the market demand.

Stringent Regulatory Guidelines Expected to Elevate the Pathogen Reduction Systems Market Value

Regulatory bodies have stringent guidelines and standards for blood safety. These are designed for the well-being of the population and compel healthcare facilities, blood banks, and transfusion centers to incorporate pathogen reduction systems, adding to the overall market value. Premises that are approved by regulatory bodies for their practices help in the development of trust amongst the general public. Thus, the stringent guidelines and recommendations for blood safety by regulatory agencies are expected to contribute to the market growth.

Increasing Incidence of Bloodborne Diseases to Boost Pathogen Reduction Systems Market Size

The market is experiencing a rise in the incidence of bloodborne diseases, such as HIV, hepatitis B, and hepatitis C, which is driving the demand for pathogen reduction systems. Healthcare providers are increasingly adopting advanced technologies to ensure that the blood products that are assigned for transfusion are safe for patients. With the increase in the cases of bloodborne diseases, the demand for the market in the healthcare sector is likely to grow in the forecast period.

Pathogen Reduction Systems Market Segmentation

Market Breakup by Automation

• Semi-Automated Pathogen Reduction System

• Fully Automated Pathogen Reduction System

Market Breakup by Type

• Platelet Pathogen Reduction

• Plasma Pathogen Reduction

Market Breakup by Application

• Viruses

• Fungi

• Bacteria

• Others

Market Breakup by End User

• Hospitals

• Ambulatory Surgical Centre

• Blood Banks

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Pathogen Reduction Systems Market Share

Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth

The market share is segmented by type into platelet pathogen reduction and plasma pathogen reduction systems. The platelet pathogen reduction segment includes the pathogen reduction technologies that help in reducing the pathogen contamination in platelets before transfusion. On the other hand, the plasma pathogen reduction segment involves the treatment of plasma to inactivate pathogens. These pathogen reduction technologies ensure the safety of plasma used in transfusions or the production of plasma-derived therapies.

 
Pathogen Reduction Systems Market Analysis by Region

Based on region, North America is anticipated to account for the largest share of the market for pathogen reduction systems owing to the presence of a well-established healthcare system and high healthcare expenditure in the region. Additionally, the market share can also be attributed to the rising adoption of advanced products and the rising investment by the government. Besides North America, the rapidly developing Asia Pacific region is also set to register remarkable growth over the coming years due to the rising emphasis of the government on the development and expansion of the healthcare sector.

Leading Players in the Pathogen Reduction Systems Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Terumo BCT, Inc.

Terumo BCT is headquartered in Colorado and is a subsidiary of Terumo Corp. It is a leading player in the market known for offering blood components, cellular technologies, and therapeutic apheresis. Its pathogen reduction technologies provide innovative and reliable solutions in blood management and transfusion safety.

Macopharma SA

Medical device company Macopharma SA specializes in the development and manufacturing of infusion, transfusion, and biotherapy systems. Theraflex MB – Plasma pathogen reduction system is one of the key products of the company that is designed to inactivate pathogens in plasma.

Cerus Corporation

Cerus Corporation, a medical equipment manufacturer in Concord, California, manufactures systems that help in enhancing the safety of blood transfusions. The company is known for its INTERCEPT Blood System that is widely used for pathogen inactivation in blood components.

AngioDynamics, Inc.

Headquartered in New York, United States, this medical technology company contributes significantly to the pathogen reduction systems market. AngioDynamics' focus on innovation and technology positions helps it to maintain a robust presence in the pathogen reduction space.

Other key players in the market include Octapharma AG and Pathogen Reduction Solutions Ltd.

Key Highlights of the Report

Key Questions Answered in the Pathogen Reduction Systems Market Report

• What was the global pathogen reduction systems market value in 2023?
• What is the global pathogen reduction systems market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on automation?
• What is the market breakup based on type?
• What is the market breakup by application?
• Who are the major end users in the market?
• What are the major factors aiding the global pathogen reduction systems market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• How do the prevalence and incidence of bloodborne diseases affect the market landscape?
• What are the major global pathogen reduction systems market trends?
• How do the advancements in pathogen reduction systems impact the market size?
• Which automation type will dominate the market share? 
• Which type of pathogen reduction system is likely to lead the market share?
• Which application is expected to have a high market value in the coming years?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the pathogen reduction systems market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?